Latest Reports
Global Anti-Hypertensive Drug Market Size, Share, Opportunities, And Trends By Drug Class (Diuretics, Beta-Blockers, ACI Inhibitors, Calcium Channel Blockers, Combined Alpha and Beta-Blockers, Others), By Type (Primary Hypertension, Secondary Hypertension), By Sales Channel (Prescription, Over-the-counter (OTC)), And By Geography - Forecasts From 2025 To 2030
The global anti-hypertensive drug market is estimated to grow at a CAGR of 2.88% to reach a market size of US$47.241 billion in 2030 from US$41.082 billion in 2025. The global anti-hypertensive drug market is poised to surge at substanti...
Global Prescription Drugs Market Size, Share, Opportunities, And Trends By Type (Generics, Orphan Drugs, Others), By Application (Diabetes, Oncology, Cardiovascular Diseases, Autoimmune Diseases, Others), By Distribution Channel (Hospital Pharmacy, Drug Stores & Retail Pharmacy, Online Pharmacy), And By Geography- Forecasts From 2025 To 2030
The global prescription drug market is estimated to augment at a CAGR of 4.67%, increasing from US$1,268.008 billion in 2025 to US$1,593.019 billion by the end of 2030. Prescription drugs are more potent in comparison to over-the-counter (...
Peripheral Vascular Intervention Market - Strategic Insights and Forecasts (2025-2030)
The peripheral vascular intervention market is estimated to grow at a CAGR of 5.74% to reach a market size of US$18.198 billion in 2030 from US$13.765 billion in 2025. Peripheral vascular interventions are interventional treatments acces...
Myasthenia Gravis Treatment Market Size, Share, Opportunities, And Trends By Application (Cloud, On-Premise), By End User (Hospitals, Clinics, Others), And By Geography - Forecasts from 2025 To 2030
The myasthenia gravis treatment market is estimated to grow at a CAGR of 7.14%, from US$2.785 billion by 2030 to US$1.973 billion in 2025. Myasthenia gravis is a type of chronic neuromuscular disease that generally causes weakness in the v...
Global Immunosuppressant Drugs Market Size, Share, Opportunities, And Trends By Drug Class (Calcineurin Inhibitors, mTOR inhibitor, Antibodies, Others), By Application (Organ Transplantation, Autoimmune Disorder), By Distribution Channel (Online, Offline), And By Geography - Forecasts From 2025 To 2030
The global Immunosuppressant Drugs market is expected to grow at a CAGR of 12.42%, reaching a market size of US$76.719 billion in 2030 from US$42.721 billion in 2025. Immunosuppressive drugs find their clinical utility in managing autoimmu...
Spinal Muscular Atrophy Treatment Market Size, Share, Opportunities, And Trends By Type (Type 1, Type 2, Type 3, Type 4), By Drug (Spinraza, Zolgensma, Evrysdi, Others), By Route of Administration (Oral, Injection), And By Geography - Forecasts From 2024 To 2029
The spinal muscular atrophy treatment market is estimated to grow from US$4.824 billion in 2022 to US$7.716 billion in 2029 at 6.94% (CAGR). Spinal muscular atrophy is a disorder that affects the motor neurons, thereby causing them to lose ...
Canada Anti-Rheumatic Drug Market - Strategic Insights and Forecasts (2022-2027)
Canada’s antirheumatic drugs market was evaluated at US$726.142 million for the year 2020, growing at a CAGR of 2.18% reaching the market size of US$844.656 million by the year 2027. The need for antirheumatic medications in Canada i...
Veterinary API Market Size, Share, Opportunities, And Trends By Product Type (Antiparasitic, Anti-infectives, Vaccines, NSAIDs, Others), By Service Type (In House, Contract Outsourcing, Contract Development, Contract Manufacturing), By Synthesis Type (OMICS Chemical-Based API, Biological API, Highly Potent API (HPAPI)), By Route of administration (Oral, Injectable, Topical, Others), And By Geography - Forecasts From 2024 To 2029
The Veterinary API market is projected to grow at a CAGR of 8.28% from estimated value of US$7.925 billion in 2024 to US$11.794 billion in 2029. Advances in veterinary medicine, growing pet ownership, and the growing need for animal health...
Herpes Simplex Virus Treatment Market Size, Share, Opportunities, And Trends By Treatment (Herpes Simplex Virus-1, Herpes Simplex Virus-2), By Drug (Acyclovir, Valacyclovir, Famciclovir, Others), By End-User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), And By Geography - Forecasts From 2024 To 2029
The herpes simplex virus treatment market is estimated to grow at a CAGR of 4.12% during the forecast period. Herpes, also known as herpes simplex virus (HSV), is a common illness that can result in painful blisters or ulcers. Oral herpes ...
High Potency API Contract Manufacturing Market Size, Share, Opportunities, And Trends By Product Type (Innovative, Generic), By Synthesis (Synthetic, Biotech), By Dosage Form (Injectable, Oral Solids, Creams, Others), By Application (Oncology, Hormonal Disorders, Glaucoma, Others), And By Geography - Forecasts From 2024 To 2029
The high-potency API contract manufacturing market is expected to witness significant growth during the forecasted period. The market for contract manufacturing of high-potency active pharmaceutical ingredients (HPAPI) has grown significan...
Liposomal Doxorubicin Market Size, Share, Opportunities, And Trends By Type (Branded, Generic), By Application (Breast Cancer, Ovarian Cancer, AIDS-related, Kaposi's Sarcoma, Multiple Myeloma, Other Solid Tumors), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Mail-Order Pharmacies), And By Geography - Forecasts From 2024 To 2029
The liposomal doxorubicin market is expected to witness significant growth during the forecasted period. The pharmaceutical formulation of the anticancer medication doxorubicin enclosed in liposomes is the focal point of the liposomal doxo...
PCSK9 Inhibitor Market Size, Share, Opportunities, And Trends By Drug Type (Repatha (Evolocumab), Praluent (Alirocumab), Bococizuma, Others), By Modality (Fully humanized monoclonal antibodies, siRNA), By Application (Clinical Application, Drug Development, Other), And By Geography - Forecasts From 2024 To 2029
The PCSK9 inhibitor market has experienced significant growth due to its effectiveness in managing cholesterol levels, particularly in patients with familial hypercholesterolemia or those intolerant to statins. These inhibitors, such as evo...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.